Product: IDArubicin Hydrochloride Injection USP 5gm/5mL (1mg/mL) for intravenous use, 5mL Single Dose Vial, Rx Only, Teva Pharmaceuticals, USA, Inc., North Wales, PA 19454, NDC 0703-4154-11.
Reason for recall: Presence of Particulate Matter: Product was found to contain silica and iron oxide
Recall initiated: 20220329
Status: Terminated
Classification: Class I
Recall type: Voluntary: Firm initiated